Genmab A/S (GMAB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Novo Nordisk A/S

H. Lundbeck A/S

Zealand Pharma A/S

Bavarian Nordic A/S

Orphazyme A/S

Genmab A/S

Why is Genmab A/S ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Genmab A/S for you?

Low Risk, High Return

Absolute

Risk Adjusted

Volatility

Genmab A/S

20.26%

19.48

34.38%

OMX Copenhagen 20

-24.94%

-0.70

35.84%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.34%

EBIT Growth (5y)

5.35%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.61

Sales to Capital Employed (avg)

0.46

Tax Ratio

13.91%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.04%

ROCE (avg)

125.56%

ROE (avg)

18.85%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.96

EV to EBIT

16.21

EV to EBITDA

16.21

EV to Capital Employed

2.22

EV to Sales

5.43

PEG Ratio

Dividend Yield

ROCE (Latest)

13.67%

ROE (Latest)

18.89%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Genmab A/S

Net Sales - Quarterly

At DKK 4,143 MM has Grown at 46.19 %

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (DKK MM)

Profit After Tax (PAT) - Quarterly

At DKK 1,325 MM has Grown at 531.0 %

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (DKK MM)

Operating Cash Flow - Annually

Highest at DKK 7,380.00 MM and Grown

each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (DKK MM)

Profit Before Tax less Other Income (PBT) - Quarterly

At DKK 794 MM has Grown at 93.19 %

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (DKK MM)

Here's what is not working for Genmab A/S

Non Operating Income - Quarterly

is 53.73 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT (DKK MM)

Inventory Turnover Ratio- Half Yearly

Lowest at 167.58 times

in the last five half yearly periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio